← FDA Drug Approvals (Drugs@FDA)
TRIAMTERENE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AGNITIO · Approved 2019-08-19
Drug application
- FDA Application #
ANDA211581- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRIAMTERENE
- Generic name
- TRIAMTERENE CAPSULES
- Active ingredients
- TRIAMTERENE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AGNITIO
- Manufacturer
- TRUPHARMA LLC
- First approval
- 2019-08-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown